Accad M, Farese RV Jr (1998) Cholesterol homeostasis: A role for oxysterols. Curr. Biol. 8:R601–R604.
Bersot TP, Mahley RW (1998) A preliminary report on the sensitivity of plasma lipoproteins to low-dose simvastatin in nine Turkish men. Arch. Turk. Soc. Cardiol. 26:40–46.
Borén J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL (1998) Identification of the low density lipoprotein receptor–binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J. Clin. Invest. 101:1084–1093.
Borén J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL (1998) Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J. Clin. Invest. 101:2658–2664.
Borén J, Véniant MM, Young SG (1998) Apo B100–containing lipoproteins are secreted by the heart. J. Clin. Invest. 101:1197–1202.
Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2–/– mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894–897.
Cases S, Novak S, Zheng Y-W, Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, Farese RV Jr (1998) ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273:26755–26764.
Cases S, Smith SJ, Zheng Y-W, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, Erickson SK, Farese RV Jr (1998) Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. USA 95:13018–13023.
Ceska R, Horinek A, Sobra J, Weisgraber KH, Innerarity T, Slezka V (1998) FDB: Diagnosis, laboratory and clinical findings, possibilities of treatment. Experience from homozygous and heterozygous patients. In: Atherosclerosis XI (Jacotot B, Mathe D, Fruchart J-C, eds) Elsevier, Amsterdam, pp 739–743.
Coward P, Wada HG, Falk MS, Chan SDH, Meng F, Akil H, Conklin BR (1998) Controlling signaling with a specifically designed Gi-coupled receptor. Proc. Natl. Acad. Sci. USA 95:352–357.
DeYoung MB, Dichek DA (1998) Gene therapy for restenosis. Are we ready? Circ. Res. 82:306–313.
Dichek HL, Brecht W, Fan J, Ji Z-S, McCormick SPA, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley RW (1998) Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. Biol. Chem. 273:1896–1903.
Dong L-M, Innerarity TL, Arnold KS, Newhouse YM, Weisgraber KH (1998) The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: Role in receptor-binding activity. J. Lipid Res. 39:1173–1180.
Fan J, Ji Z-S, Huang Y, de Silva H, Sanan D, Mahley RW, Innerarity TL, Taylor JM (1998) Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J. Clin. Invest. 101:2151–2164.
Farese RV Jr (1998) Acyl CoA:cholesterol acyltransferase genes and knockout mice. Curr. Opin. Lipidol. 9:119–123.
Farese RV Jr, Cases S, Novak S (1998) Intracellular sterol esterification: Two acyl CoA:cholesterol acyltransferases in mammals. In: Intracellular Cholesterol Trafficking (Chang TY, Freeman DA, eds) Kluwer, Boston, pp 29–42.
Farese RV Jr, Herz J (1998) Cholesterol metabolism and embryogenesis. Trends Genet. 14:115–120.
Gerszten RE, Lim Y-C, Ding HT, Snapp K, Kansas G, Dichek DA, Cabañas C, Sánchez-Madrid F, Gimbrone MA Jr, Rosenzweig A, Luscinskas FW (1998) Adhesion of monocytes to vascular cell adhesion molecule-1–transduced human endothelial cells. Implications for atherogenesis. Circ. Res. 82:871–878.
Hamilton RL, Wong JS, Cham CM, Nielsen LB, Young SG (1998) Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J. Lipid Res. 39:1543–1557.
Hersberger M, Innerarity TL (1998) Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J. Biol. Chem. 273:9435–9442.
Huang Y, Liu XQ, Rall SC Jr, Mahley RW (1998) Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins. J. Biol. Chem. 273:17483–17490.
Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von Eckardstein A, Assmann G, Mahley RW (1998) Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. J. Biol. Chem. 273:26388–26393.
Ji Z-S, Pitas RE, Mahley RW (1998) Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J. Biol. Chem. 273:13452–13460.
Kahn ML, Zheng Y-W, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, Coughlin SR (1998) A dual thrombin receptor system for platelet activation. Nature 394:690–694.
Khelef N, Buton X, Beatini N, Wang H, Meiner V, Chang T-Y, Farese RV Jr, Maxfield FR, Tabas I (1998) Immunolocalization of acyl-coenzyme A:cholesterol O-acyltransferase in macrophages. J. Biol. Chem. 273:11218–11224.
Kim E, Ambroziak P, Véniant MM, Hamilton RL, Young SG (1998) A gene-targeted mouse model for familial hypobetalipoproteinemia. Low levels of apolipoprotein B mRNA in association with a nonsense mutation in exon 26 of the apolipoprotein B gene. J. Biol. Chem. 273:33977–33984.
Kim E, Cham CM, Véniant MM, Ambroziak P, Young SG (1998) Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the Apob gene. J. Clin. Invest. 101:1468–1477.
Kim E, Young SG (1998) Genetically modified mice for the study of apolipoprotein B. J. Lipid Res. 39:703–723.
Mahley RW (1998) Expanding roles for apolipoprotein E in health and disease. In: Atherosclerosis XI (Jacotot B, Mathé D, Fruchart J-C, eds) Elsevier, Amsterdam, pp 117–124.
Mahley RW, Weisgraber KH, Farese RV Jr (1998) Disorders of lipid metabolism. In: Williams Textbook of Endocrinology, 9th edition (Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds) WB Saunders, Philadelphia, pp 1099–1153.
McCormick SPA, Nielsen LB (1998) Expression of large genomic clones in transgenic mice: New insights into apolipoprotein B structure, function and regulation. Curr. Opin. Lipidol. 9:103–111.
Meiner VL, Welch CL, Cases S, Myers HM, Sande E, Lusis AJ, Farese RV Jr (1998) Adrenocortical lipid depletion gene (ald) in AKR mice is associated with an acyl-CoA:cholesterol acyltransferase (ACAT) mutation. J. Biol. Chem. 273:1064–1069.
Meyer SC, Sanan DA, Fox JEB (1998) Role of actin-binding protein in insertion of adhesion receptors into the membrane. J. Biol. Chem. 273:3013–3020.
Mietus-Snyder M, Glass CK, Pitas RE (1998) Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBPb. Both AP-1 binding and JNK activation are induced by phorbol esters and oxidative stress. Arterioscler. Thromb. Vasc. Biol. 18:1440–1449.
Mozes G, Mohacsi T, Gloviczki P, Menawat S, Kullo I, Spector D, Taylor J, Crotty TB, O’Brien T (1998) Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arterioscler. Thromb. Vasc. Biol 18:1157–1163.
Nielsen LB, Kahn D, Duell T, Weier H-UG, Taylor S, Young SG (1998) Apolipoprotein B gene expression in a series of human apolipoprotein B transgenic mice generated with recA-assisted restriction endonuclease cleavage-modified bacterial artificial chromosomes. An intestine-specific enhancer element is located between 54 and 62 kilobases 5′ to the structural gene. J. Biol. Chem. 273:21800–21807.
Nielsen LB, Véniant M, Borén J, Raabe M, Wong JS, Tam C, Flynn L, Vanni-Reyes T, Gunn MD, Goldberg IJ, Hamilton RL, Young SG (1998) Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart. Evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation 98:13–16.
Pitas RE, Ji Z-S, Supekova L, Mahley RW (1998) Divergent metabolism of apolipoproteins E3 and E4 by cells. In: Progress in Alzheimer’s and Parkinson’s Diseases (Fisher A, Hanin I, Yoshida M, eds) Plenum, New York, pp 17–23.
Pitas RE, Ji Z-S, Weisgraber KH, Mahley RW (1998) Role of apolipoprotein E in modulating neurite outgrowth: Potential effect of intracellular apolipoprotein E. Biochem. Soc. Trans. 26:257–262.
Powell-Braxton L, Véniant M, Latvala RD, Hirano K-I, Won WB, Ross J, Dybdal N, Zlot CH, Young SG, Davidson NO (1998) A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat. Med. 4:934–938.
Qian X, Balestra ME, Yamanaka S, Borén J, Lee I, Innerarity TL (1998) Low expression of the apolipoprotein B mRNA–editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler. Thromb. Vasc. Biol. 18:1013–1020.
Qiu C, De Young MB, Finn A, Dichek DA (1998) Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and av-integrins. Hum. Gene Ther. 9:507–520.
Raabe M, Flynn LM, Zlot CH, Wong JS, Véniant MM, Hamilton RL, Young SG (1998) Knockout of the abetalipoproteinemia gene in mice: Reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. USA 95:8686–8691.
Raabe M, Kim E, Véniant M, Nielsen LB, Young SG (1998) Using genetically engineered mice to understand apolipoprotein-B deficiency syndromes in humans. Proc. Am. Assoc. Physicians 110:521–530.
Raabe M, Linton MF, Young SG (1998) Long runs of adenines and human mutations. Am. J. Med. Genet. 76:101–102.
Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females. Proc. Natl. Acad. Sci. USA 95:10914–10919.
Rall SC Jr, Ye P, Bu G, Wardell MR (1998) The domain structure of human receptor-associated protein. Protease sensitivity and guanidine HCl denaturation. J. Biol. Chem. 273:24152–24157.
Rozek A, Sparrow JT, Weisgraber KH, Cushley RJ (1998) Sequence-specific 1H NMR resonance assignments and secondary structure of human apolipoprotein C-I in the presence of sodium dodecyl sulfate. Biochem. Cell Biol. 76:267–275.
Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH (1998) Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a). Proc. Natl. Acad. Sci. USA 95:4544–4549.
Schneider DB, Fly CA, Dichek DA, Geary RL (1998) Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primates. Hum. Gene Ther. 9:815–821.
Schulick AH, Taylor AJ, Zuo W, Qiu C-B, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA (1998) Overexpression of transforming growth factor b1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc. Natl. Acad. Sci. USA 95:6983–6988.
Segrest JP, Jones MK, Mishra VK, Pierotti V, Young SG, Borén J, Innerarity TL, Dashti N (1998) Apolipoprotein B-100: Conservation of lipid-associating amphipathic secondary structural motifs in nine species of vertebrates. J. Lipid Res. 39:85–102.
Taylor JM (1998) Apolipoprotein E and hepatic lipase transgenic rabbit models for the study of atherosclerosis. In: New Advances in Vascular Biology and Molecular Cardiovascular Medicine (Schwinn DA, ed) Williams & Wilkins, Baltimore, pp 125–134.
Tran K, Borén J, Macri J, Wang Y, McLeod R, Avramoglu RK, Adeli K, Yao Z (1998) Functional analysis of disulfide linkages clustered within the amino terminus of human apolipoprotein B. J. Biol. Chem. 273:7244–7251.
Tsou C-L, Gladue RP, Carroll LA, Paradis T, Boyd JG, Nelson RT, Neote K, Charo IF (1998) Identification of C–C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C–C chemokine (HCC)–1 receptor. J. Exp. Med. 188:603–608.
Vassalli G, Dichek DA (1998) Cardiovascular gene therapy. In: Principles of Molecular Medicine (Jameson JL, ed) Humana Press, Totowa, NJ, pp 161–168.
Vega GL, Gao J, Bersot TP, Mahley RW, Verstraete R, Grundy SM, White A, Cohen JC (1998) The –514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. J. Lipid Res. 39:1520–1524.
Véniant MM, Zlot CH, Walzem RL, Pierotti V, Driscoll R, Dichek D, Herz J, Young SG (1998) Lipoprotein clearance mechanisms in LDL receptor–deficient “apo-B48-only” and “apo-B100-only” mice. J. Clin. Invest. 102:1559–1568.
Young SG, Schneider WJ (1998) Genetics and molecular biology. Curr. Opin. Lipidol. 9:81–83.
Zhu Y, Bellosta S, Langer C, Bernini F, Pitas RE, Mahley RW, Assmann G, von Eckardstein A (1998) Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma. Proc. Natl. Acad. Sci. USA 95:7585–7590.
TOP
